ViroMissile, Inc. has welcomed Michael G. Wood as their new Chief Business Officer. This move is big news for the company, which is working on a new way to fight cancer using viruses. Wood's job will be to help the company grow, find money for projects, and make important deals. Wood has a lot of e
Cancer is tough to beat, but scientists are always looking for new ways to fight it. Recently, a team came up with a clever idea. They made tiny particles that can help the body's own immune system attack cancer cells. These particles are special because they use sound waves to do their job. Normal
In the world of cancer treatment, scientists are always looking for new ways to make therapies more effective. One exciting area of research is using tiny organisms, like bacteria, to help with a type of treatment called CAR-based immunotherapy. This therapy uses specially engineered immune cells to
Recent findings suggest that mRNA COVID-19 vaccines, like those from Pfizer and Moderna, could offer a surprising advantage for advanced cancer patients. The research, published in Nature, indicates that these vaccines might enhance the effectiveness of cancer immunotherapy. The study focused on pa
Cancer treatment has seen a major shift with the introduction of immune checkpoint blockade. This method has led to significant improvements in long-term outcomes and survival rates, especially when combined with other treatments. However, not everyone benefits from these treatments. Some patients f
Cancer treatment has changed a lot with immunotherapy. But herein lies the problem. Some patients do not respond well to treatment. This is on top of having to deal with serious side effects caused by the immune system going into overdrive. Scientists have found a novel way to tackle this
The internet has long become a hot spot for people to voice their thoughts, experiences, and questions about cancer immunotherapy. Doctors and researchers might have a clear understanding of this cancer treatment, but what about everyone else? With the rise of immunotherapy in the medical field, it'
Triple-negative breast cancer (TNBC) is tough to tackle due to issues like poor blood vessels and high tumor cell load. These problems make it hard for CAR-T cells, a type of immune cell therapy, to work well. Researchers found that when there are fewer CAR-T cells compared to tumor cells, the immun
Imagine this: a brain chemical that messes with your mood also plays a big role in cancer. That’s what researchers found out about something called Monoamine Oxidase A, or MAO-A. This stuff is like a switch that can turn immune cells from sleepy to superhero in tumors. Normally, MAO-A breaks down br
